3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
147
Leukemia, Lymphocytic, Chronic, B-Cell
140
Lymphoma
116
Lymphoma, Non-Hodgkin
112
Leukemia, Myeloid, Acute
95
Leukemia
92
Myelodysplastic Syndromes
90
Hodgkin Disease
68
Lymphoma, B-Cell
61
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
53
Multiple Myeloma
52
Lymphoma, Mantle-Cell
52
Lymphoma, Large B-Cell, Diffuse
50
Lymphoma, Follicular
50
Recurrence
43
Burkitt Lymphoma
41
Hematologic Neoplasms
36
Myeloproliferative Disorders
31
Lymphoma, B-Cell, Marginal Zone
30
Neoplasms, Plasma Cell
20
Primary Myelofibrosis
19
Leukemia, Biphenotypic, Acute
18
Anemia, Refractory, with Excess of Blasts
18
Lymphoma, T-Cell
17
Leukemia, Myelomonocytic, Chronic
15
Graft vs Host Disease
15
Anemia, Aplastic
15
Leukemia, Prolymphocytic
14
Neoplasms
12
Leukemia, B-Cell
12
Interventions
Rituximab
4
Doxorubicin
3
Cyclophosphamide
3
Vincristine
2
Prednisone
2
Etoposide
2
pomalidomide
1
merphos
1
fludarabine
1
brincidofovir
1
Zidovudine
1
Tomography, X-Ray Computed
1
Polymerase Chain Reaction
1
Nivolumab
1
Methotrexate
1
Leucovorin
1
Interferons
1
In Situ Hybridization
1
Immunohistochemistry
1
Hydroxyurea
1
Flow Cytometry
1
Echocardiography
1
EPOCH protocol
1
Cytogenetic Analysis
1
Caves
1
Brentuximab Vedotin
1
Blotting, Western
1
AP 1903 reagent
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Epstein-Barr Virus Infections
×
fludarabine
×
Lymphoid
×
Clear all
NCT06224049
2024-03-12
GI-hNeoT-01
BGI, China
Phase EARLY_PHASE1
Recruiting
6 enrolled